Search research articles
Contact Us
Filters
Showing results (61-70 of 141) with videos related to
Page
of 15
Sort By:
Blood Cancer Journal
|
June 13, 2024
Multi-target measurable residual disease assessed by error-corrected sequencing in patients with acute myeloid leukemia: An ALFA study
Pierre Hirsch, Jérôme Lambert, Maxime Bucci, et al.
Leukemia
|
March 11, 2021
Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies
Melanie Decker, Tim Lammens, Alina Ferster, et al.
Leukemia
|
March 8, 2022
Molecular heterogeneity and measurable residual disease of rare NPM1 mutations in acute myeloid leukemia: a nationwide experience from the GBMHM study group
Elise Fournier, Maël Heiblig, Christine Lespinasse, et al.
Leukemia
|
February 17, 2024
Clinical impact of genetic alterations including germline DDX41 mutations in MDS/low-blast count AML patients treated with azacitidine-based regimens
Marie Sébert, Lucie Freiman, Cendrine Chaffaut, et al.
BMC Bioinformatics
|
December 10, 2022
Publisher Correction: Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3r
Augustin Boudry, Sasha Darmon, Nicolas Duployez, et al.
BMC Bioinformatics
|
October 28, 2022
Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3r
Augustin Boudry, Sasha Darmon, Nicolas Duployez, et al.
Nature Communications
|
March 25, 2023
Clonal origin and development of high hyperdiploidy in childhood acute lymphoblastic leukaemia
Eleanor L Woodward, Minjun Yang, Larissa H Moura-Castro, et al.
Leukemia
|
June 29, 2018
Polycomb repressive complex 2 haploinsufficiency identifies a high-risk subgroup of pediatric acute myeloid leukemia
Jonathan Bond, Elise Labis, Alice Marceau-Renaut, et al.
American Journal of Hematology
|
October 26, 2018
Comprehensive molecular landscape in patients older than 80 years old diagnosed with acute myeloid leukemia: A study of the French Hauts-de-France AML observatory
Loïc Renaud, Olivier Nibourel, Alice Marceau-Renaut, et al.
British Journal of Haematology
|
September 3, 2025
Monitoring of measurable residual disease by next-generation sequencing in patients with acute myeloid leukaemia
Augustin Boudry, Laure Goursaud, Delphine Lebon, et al.
Page
of 15
Search research articles
Search
Showing results (61-70 of 141) with videos related to
Sort By:
Page
of 15
Blood Cancer Journal
|
June 13, 2024
Multi-target measurable residual disease assessed by error-corrected sequencing in patients with acute myeloid leukemia: An ALFA study
Pierre Hirsch, Jérôme Lambert, Maxime Bucci, et al.
Leukemia
|
March 11, 2021
Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies
Melanie Decker, Tim Lammens, Alina Ferster, et al.
Leukemia
|
March 8, 2022
Molecular heterogeneity and measurable residual disease of rare NPM1 mutations in acute myeloid leukemia: a nationwide experience from the GBMHM study group
Elise Fournier, Maël Heiblig, Christine Lespinasse, et al.
Leukemia
|
February 17, 2024
Clinical impact of genetic alterations including germline DDX41 mutations in MDS/low-blast count AML patients treated with azacitidine-based regimens
Marie Sébert, Lucie Freiman, Cendrine Chaffaut, et al.
BMC Bioinformatics
|
December 10, 2022
Publisher Correction: Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3r
Augustin Boudry, Sasha Darmon, Nicolas Duployez, et al.
BMC Bioinformatics
|
October 28, 2022
Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3r
Augustin Boudry, Sasha Darmon, Nicolas Duployez, et al.
Nature Communications
|
March 25, 2023
Clonal origin and development of high hyperdiploidy in childhood acute lymphoblastic leukaemia
Eleanor L Woodward, Minjun Yang, Larissa H Moura-Castro, et al.
Leukemia
|
June 29, 2018
Polycomb repressive complex 2 haploinsufficiency identifies a high-risk subgroup of pediatric acute myeloid leukemia
Jonathan Bond, Elise Labis, Alice Marceau-Renaut, et al.
American Journal of Hematology
|
October 26, 2018
Comprehensive molecular landscape in patients older than 80 years old diagnosed with acute myeloid leukemia: A study of the French Hauts-de-France AML observatory
Loïc Renaud, Olivier Nibourel, Alice Marceau-Renaut, et al.
British Journal of Haematology
|
September 3, 2025
Monitoring of measurable residual disease by next-generation sequencing in patients with acute myeloid leukaemia
Augustin Boudry, Laure Goursaud, Delphine Lebon, et al.
Page
of 15